The Rivkin Center has awarded Dr. Zachary Watson, PhD, assistant professor atUniversity of Colorado School of Medicine, a $75,000 grant to investigate the development of ovariancancer in post-menopausal women. Rivkin Center Pilot Study Awards fund novel, innovative ideas thatare in the early stages of discovery. About his research: Dr. Watson will investigate a potential driver […]
Read MoreResearch to help fast-track new treatment for low-grade serous ovarian cancer Seattle, WA – The Rivkin Center has awarded Dr. Utthara Nayar, PhD, associate professor at theJohns Hopkins University’s Bloomberg School of Health, a $75,000 grant to help her fast-track clinicaltesting of a new treatment for ovarian cancer. Rivkin Center Pilot Study Awards fund novel, […]
Read MoreScientific awards also given to researchers at Johns Hopkins University and University of Colorado Seattle, WA – In a bold move for ovarian cancer research in Washington state, the Rivkin Center forOvarian Cancer Research, in partnership with the state’s Andy Hill Cancer Research Endowment (CARE)Fund, announced today the 2024 recipients of the new Rivkin Center/CARE […]
Read MoreFunds to support innovation and answers in WA state research institutions Sept. 21, 2023 For Immediate Release Molly O’Connor, CEO(206) 490-0878; molly.oconnor@rivkin.org SEATTLE – Washington state ovarian cancer researchers will have an extra $1M in grant funding over the next two years thanks to a pioneering public-private partnership between the Rivkin Center for Ovarian Cancer […]
Read More
To say that a cure for ovarian cancer, or any cancer for that matter, is the “holy grail” of cancer research is like saying the sky is blue. We all know a cure is the goal. If a cure is the goal, then improved detection, new prevention methods, and new treatments are the low-hanging fruit. […]
Read More